skinny.

Latest / The HemOnc Pulse

What Is the Cost-Effectiveness of Pola-R-CHP in DLBCL?

Swetha Kambhampati, MD, and Nikhil Thiruvengadam, MD, discuss the implications of their study investigating the cost-effectiveness of pola-R-CHP in previously untreated DLBCL.

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.